@Gitmo I agree that the burns and safety data will be more interesting, as the bacteriacidal properties are the primary focus. Are doses higher in the antiviral application? As my toxicology lecturer used to say 'it is the dose that makes the poison'
Ann: R327 to Stage 2 of SARS-CoV-2 Antiviral Screening at CSIRO, page-37
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $37.25K | 127.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 161128 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 9666 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |